Skip to main content
. 2018 Feb 21;9(32):22546–22558. doi: 10.18632/oncotarget.24547

Table 3. A list of components that present high spearman correlation in the MCPM regarding panobinostat.

Drug type Component Metabolic pathway Correlation / P value
Panobinostat ATP6V0E1 Purine 0.3775625 p=2.262852e-17
Panobinostat UPP1 Pyrimidine 0.3762676 p=2.963006e-17
Panobinostat 3,4-Dihydroxymandelate Tyrosine 0.3723126 p=3.021123e-17
Panobinostat PAPSS2 Purine 0.3375621 p=5.454525e-14
Panobinostat NT5E Purine, pyrimidine 0.3049326 p=1.431208e-11

These components and reactions are from purine, pyrimidine and tyrosine pathways